Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NGM Biopharmaceuticals In...

    NASDAQ: NGM · Real-Time Price · USD
    1.54
    -0.02 (-1.28%)
    At close: Apr 03, 2024, 3:59 PM

    NGM Biopharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 4.42M 55.33M 77.88M
    Cost of Revenue
    		 2.22M 5.98M 7.9M
    Gross Profit
    		 2.2M 49.35M 69.98M
    Operating Income
    		 -146.55M -166.25M -120.69M
    Interest Income
    		 9.32M 3.71M 420K
    Pretax Income
    		 -142.38M -162.67M -120.33M
    Net Income
    		 -142.38M -159.09M -113.83M
    Selling & General & Admin
    		 36.73M 40.52M 36.87M
    Research & Development
    		 112.01M 181.07M 161.71M
    Other Expenses
    		 -234K -132K -60K
    Operating Expenses
    		 148.74M 221.58M 198.58M
    Interest Expense
    		 n/a 3.71M n/a
    Selling & Marketing Expenses
    		 -1.1M n/a n/a
    Cost & Expenses
    		 150.96M 221.58M 198.58M
    Income Tax Expense
    		 n/a -3.58M -6.51M
    Shares Outstanding (Basic)
    		 82.5M 79.95M 77.09M
    Shares Outstanding (Diluted)
    		 82.5M 79.95M 77.09M
    EPS (Basic)
    		 -1.73 -1.99 -1.48
    EPS (Diluted)
    		 -1.73 -1.99 -1.48
    EBITDA
    		 -144.33M -166.25M -120.69M
    EBIT
    		 -146.55M -158.95M n/a
    Depreciation & Amortization
    		 2.22M 4.04M 6.09M

    Add to Watchlist